Molecular Medicine

Molecular Medicine, abbreviated as Mol Med and bearing the ISSN 1076-1551, is a premier peer-reviewed journal dedicated to advancing the understanding of disease mechanisms at the molecular level and translating these discoveries into novel therapeutic strategies. The journal’s scope encompasses a broad spectrum of biomedical research, with a strong focus on molecular pathogenesis, genetic and epigenetic regulation, cellular signaling, immunology, and the development of targeted therapies, including gene and cell-based treatments. It publishes a range of article types, including original research articles, comprehensive reviews, brief communications, and editorials, all of which undergo rigorous peer review to ensure scientific integrity and impact. The target audience includes molecular biologists, geneticists, pharmacologists, clinical researchers, and physicians seeking to bridge the gap between basic molecular science and clinical application. A notable feature of Molecular Medicine is its open access publishing model, which ensures that all content is freely and permanently available online, maximizing global dissemination and citation. The journal is published by BioMed Central, part of Springer Nature, a leader in open access scientific publishing. With an impressive Impact Factor of 8.300 as projected for 2026, the journal is firmly positioned in the Q1 quartile of the JCR category for Medicine, Research & Experimental. This high standing reflects its exceptional influence and reputation within the molecular and translational medicine community, making it a highly sought-after venue for landmark studies that drive progress from bench to bedside.